UNSPSC 51283001: Pirlimycin

This classification denotes a lincosamide antibiotic with the molecular formula C17H31ClN2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LM19JT6G5K, chemically known as l-threo-alpha-d-galacto-octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((4-ethyl-2-piperidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2s-cis)- but generally known as pirlimycin, which bears US NIH Compound Identifier 115329.

UNSPSC 51283001 Pirlimycin is a Commodity code representing a specific veterinary antibiotic pharmaceutical product, but recent state and local procurement activity tagged under this code does not reflect pirlimycin purchases. Instead, the code appears in the source alongside pharmaceutical warehouse orders and naloxone procurement activities that fall outside the nominal scope of this specific antibiotic commodity. State and local buying under the code, where it surfaces in practice, centers on emergency pharmaceutical supplies and public health initiatives rather than the narrow veterinary product the code name describes.

Issuing bodies using this code include state health departments and county government health divisions. The geographic activity documented in the source is limited to Illinois (Illinois Department of Public Health) and Florida (Seminole County). The Illinois Department of Public Health awarded a completed piggyback pharmaceutical contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over 12 months with two renewal options, sourcing Doxycycline Hyclate and Ciprofloxacin Hydrochloride through an Invitation for Bid process. Separately, Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2026 for 2,700 combined units of naloxone and safe drug deactivation systems annually via quarterly delivery). The code shows minimal recent activity with concrete pirlimycin procurement and does not demonstrate active market volume or competitive depth for this specific antibiotic commodity at the state and local level.